Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Beth Levant
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Anatomy
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
10
Carlson, Susan
9
Nemeroff, Charles
7
Ozias, Marlies
7
Bissette, Garth
6
Wang, Shaomeng
6
Pazdernik, Thomas
5
Chen, Jianyong
4
Wu, Xihan
4
Varady, Judith
3
McCarson, Kenneth
3
Radel, Jeffery
3
Richards, Toni
3
Ji, Min
3
Ding, Ke
2
Ahlgren-Beckendorf, Joy
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Beth Levant (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Chen Jianyong; Collins Gregory T; Zhang Jian; Yang Chao-Yie; Levant Beth; Woods James; Wang Shaomeng
Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.
Journal of medicinal chemistry 2008;51(19):5905-8.
-
2008: Levant Beth; Ozias Marlies K; Davis Paul F; Winter Michelle; Russell Kristin L; Carlson Susan E; Reed Gregory A; McCarson Kenneth E
Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats.
Psychoneuroendocrinology 2008;33(9):1279-92.
-
2008: Culver Kirsten E; Szechtman Henry; Levant Beth
Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
European journal of pharmacology 2008;592(1-3):67-72.
-
2008: Ahmad S Omar; Park Ji-Hyuk; Radel Jeffery D; Levant Beth
Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study.
Neuroscience letters 2008;438(3):303-7.
-
2007: Richards Toni L; Pazdernik Thomas L; Levant Beth
Basal local cerebral glucose utilization is not altered after behavioral sensitization to quinpirole.
Neuroscience letters 2007;429(2-3):165-8.
-
2007: Levant Beth; Ozias Marlies K; Carlson Susan E
Diet (n-3) polyunsaturated fatty acid content and parity affect liver and erythrocyte phospholipid fatty acid composition in female rats.
The Journal of nutrition 2007;137(11):2425-30.
-
2007: Richards Toni L; Pazdernik Thomas L; Levant Beth
Clorgyline-induced modification of behavioral sensitization to quinpirole: effects on local cerebral glucose utilization.
Brain research 2007;1160():124-33.
-
2007: Pierce Janet D; Jegathesan Jay; Levant Beth; Winter Michelle; McCarson Kenneth E; Clancy Richard L
Detection of dopamine receptor subtypes in the rat diaphragm.
Heart & lung : the journal of critical care 2007;36(1):58-63.
-
2007: Levant Beth; Ozias Marlies K; Carlson Susan E
Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet.
The Journal of nutrition 2007;137(1):130-4.
-
2007: Ozias Marlies K; Carlson Susan E; Levant Beth
Maternal parity and diet (n-3) polyunsaturated fatty acid concentration influence accretion of brain phospholipid docosahexaenoic acid in developing rats.
The Journal of nutrition 2007;137(1):125-9.
-
2006: McNamara R K; Levant B; Taylor B; Ahlbrand R; Liu Y; Sullivan J R; Stanford K; Richtand N M
C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.
Neuroscience 2006;143(1):141-53.
-
2006: Levant Beth; Radel Jeffery D; Carlson Susan E
Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in N-3 polyunsaturated fatty acids.
Biological psychiatry 2006;60(9):987-90.
-
2006: Levant Beth; Ozias Marlies K; Carlson Susan E
Sex-specific effects of brain LC-PUFA composition on locomotor activity in rats.
Physiology & behavior 2006;89(2):196-204.
-
2006: Levant Beth; Ozias Marlies K; Carlson Susan E
Diet (n-3) polyunsaturated fatty acid content and parity interact to alter maternal rat brain phospholipid fatty acid composition.
The Journal of nutrition 2006;136(8):2236-42.
-
2006: Levant Beth; Crane Jennifer F; Carlson Susan E
Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(4):728-32.
-
2006: Levant Beth; Ozias Marlies K; Jones Karra A; Carlson Susan E
Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain.
Lipids 2006;41(5):407-14.
-
2006: Chen Jianyong; Ding Ke; Levant Beth; Wang Shaomeng
Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubility.
Bioorganic & medicinal chemistry letters 2006;16(2):443-6.
-
2005: Ding Ke; Chen Jianyong; Ji Min; Wu Xihan; Varady Judith; Yang Chao-Yie; Lu Yipin; Deschamps Jeffrey R; Levant Beth; Wang Shaomeng
Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands.
Journal of medicinal chemistry 2005;48(9):3171-81.
-
2005: Richards Toni L; Pazdernik Thomas L; Levant Beth
Altered quinpirole-induced local cerebral glucose utilization in anterior cortical regions in rats after sensitization to quinpirole.
Brain research 2005;1042(1):53-61.
-
2005: Ji Min; Chen Jianyong; Ding Ke; Wu Xihan; Varady Judith; Levant Beth; Wang Shaomeng
Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
Bioorganic & medicinal chemistry letters 2005;15(6):1701-5.
-
2004: Wu Xihan; Chen Jianyong; Ji Min; Varady Judith; Levant Beth; Wang Shaomeng
Design, synthesis, and evaluation of hexahydrobenz[f]isoquinolines as a novel class of dopamine 3 receptor ligands.
Bioorganic & medicinal chemistry letters 2004;14(23):5813-6.
-
2004: Ahlgren-Beckendorf Joy A; Levant Beth
Signaling mechanisms of the D3 dopamine receptor.
Journal of receptor and signal transduction research 2004;24(3):117-30.
-
2004: Levant Beth; Radel Jeffery D; Carlson Susan E
Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation.
Behavioural brain research 2004;152(1):49-57.
-
2004: Levant Beth; Pazdernik Thomas L
Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.
Brain research 2004;1003(1-2):159-67.
-
2003: Varady Judith; Wu Xihan; Fang Xueliang; Min Ji; Hu Zengjian; Levant Beth; Wang Shaomeng
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
Journal of medicinal chemistry 2003;46(21):4377-92.
-
2003: Richtand Neil M; Welge Jeffrey A; Levant Beth; Logue Aaron D; Hayes Scott; Pritchard Laurel M; Geracioti Thomas D; Coolen Lique M; Berger S Paul
Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(8):1422-32.
-
2003: Carpenter Toni L; Pazdernik Thomas L; Levant Beth
Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats.
Brain research 2003;964(2):295-301.
-
2003: Levant Beth
Dopamine receptor binding and quantitative autoradiographic study.
Methods in molecular medicine 2003;79():297-313.
-
2002: Levant Beth
Novel drug interactions at D(2) dopamine receptors: modulation of [3H]quinpirole binding by monoamine oxidase inhibitors.
Life sciences 2002;71(23):2691-700.
-
2001: Levant B; Morgan K A; Ahlgren-Beckendorf J A; Grandy D K; Chen K; Shih J C; Seif I
Modulation of [3H]quinpirole binding at striatal D2 dopamine receptors by a monoamine oxidaseA-like site: evidence from radioligand binding studies and D2 receptor- and MAO(A)-deficient mice.
Life sciences 2001;70(2):229-41.
-
2001: Levant B; McCarson K E
D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function.
Neuroscience letters 2001;303(1):9-12.
-
2000: Gilliland S L; Alper R H; Levant B
Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile.
European journal of pharmacology 2000;392(3):125-8.
-
1999: Levant B; Garimelli B; Shafer R A; Merchant K M
Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(2):304-11.
-
1998: Levant B; Cross R S; Pazdernik T L
Alterations in local cerebral glucose utilization produced by D3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotride.
Brain research 1998;812(1-2):193-9.
-
1998: Levant B
Differential distribution of D3 dopamine receptors in the brains of several mammalian species.
Brain research 1998;800(2):269-74.
-
1998: Bancroft G N; Morgan K A; Flietstra R J; Levant B
Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;18(4):305-16.
-
1998: Shafer R A; Levant B
The D3 dopamine receptor in cellular and organismal function.
Psychopharmacology 1998;135(1):1-16.
-
1998: Levant B; Bancroft G N
Inhibition of [3H]quinpirole binding by a monoamine oxidase inhibitor in subcellular fractions of rat striatum.
Life sciences 1998;63(18):1643-51.
-
1998: Flietstra R J; Levant B
Comparison of D2 and D3 dopamine receptor affinity of dopaminergic compounds in rat brain.
Life sciences 1998;62(20):1825-31.
-
1997: Levant B
The D3 dopamine receptor: neurobiology and potential clinical relevance.
Pharmacological reviews 1997;49(3):231-52.
-
1997: Levant B; Vansell N R
In vivo occupancy of D2 dopamine receptors by nafadotride.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(2):67-71.
-
1996: Levant B; Bancroft G N; Selkirk C M
In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT.
Synapse (New York, N.Y.) 1996;24(1):60-4.
-
1996: Levant B; Moehlenkamp J D; Morgan K A; Leonard N L; Cheng C C
Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site.
The Journal of pharmacology and experimental therapeutics 1996;278(1):145-53.
-
1995: Levant B
Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Brain research 1995;698(1-2):146-54.
-
1995: Bissette G; Griff D; Carnes M; Goodman B; Lavine M; Levant B
Apparent seasonal rhythms in hypothalamic neuropeptides in rats without photoperiod changes.
Endocrinology 1995;136(2):622-8.
-
1992: Levant B; Nemeroff C B
Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.
The Journal of pharmacology and experimental therapeutics 1992;262(1):348-55.
-
1992: Myers B; Levant B; Bissette G; Nemeroff C B
Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment.
Brain research 1992;575(2):325-8.
-
1992: Levant B; Merchant K M; Dorsa D M; Nemeroff C B
BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatum.
Brain research. Molecular brain research 1992;12(4):279-84.
-
1992: Nemeroff C B; Levant B; Myers B; Bissette G
Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.
Annals of the New York Academy of Sciences 1992;668():146-56.
-
1991: Levant B; Bissette G; Davis M D; Heffner T G; Nemeroff C B
Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations.
Synapse (New York, N.Y.) 1991;9(3):225-30.
-
1991: Levant B; Bissette G; Widerlöv E; Nemeroff C B
Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugs.
Regulatory peptides 1991;32(2):193-201.
-
1991: Nemeroff C B; Kilts C D; Levant B; Bissette G; Campbell A; Baldessarini R J
Effects of the isomers of N-n-propylnorapomorphine and haloperidol on regional concentrations of neurotensin in rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1991;4(1):27-33.
-
1990: Levant B; Nemeroff C B
Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
The Journal of pharmacology and experimental therapeutics 1990;254(1):330-5.
-
1989: Levant B; Bissette G; Nemeroff C B
Effects of anticholinergic drugs on regional brain neurotensin concentrations.
European journal of pharmacology 1989;165(2-3):327-30.
-
1988: Slotkin T A; Levant B; Orband-Miller L; Queen K L; Stasheff S
Do sympathetic neurons coordinate cellular development in the heart and kidney? Effects of neonatal central and peripheral catecholaminergic lesions on cardiac and renal nucleic acids and proteins.
The Journal of pharmacology and experimental therapeutics 1988;244(1):166-72.
Sign-in to see more
